In contrast, a DL model can offer precise, AI-generated coding suggestions for adverse events and concomitant medications at up to 99% accuracy. The model can adapt to different scenarios, removing ...
Unlock the advantage of pragmatic trials and improve efficiency and real-world relevance to reduce risk and strengthen ...
Learn how early regulatory engagement, validated digital systems, and robust protocol design enable biotechs to run parallel ...
At ESMO 2025, AstraZeneca reported that Imfinzi plus BCG therapy reduced the risk of recurrence or death by 32% in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback